Current studentsExisting staffContact us
 

ARX homeodomain mutations abolish DNA binding and lead to a loss of transcriptional repression

Simple item page
dc.contributor.authorShoubridge, C.
dc.contributor.authorTan, M.
dc.contributor.authorSeiboth, G.
dc.contributor.authorGecz, J.
dc.date.issued2012
dc.description.abstractMutations in the Aristaless-related homeobox (ARX) gene are one of the most frequent causes of X-linked intellectual disability (ID). Several missense mutations, clustered in the paired-type homeodomain of ARX, have been identified. These mutations lead to a range of phenotypes from X-linked lissencephaly with abnormal genitalia to seizure disorders without brain malformations including X-linked infantile spasms with ID (ISSX-ID) and X-linked myoclonic epilepsy with spasticity and ID (XMESID). The effect of these mutations on the DNA-binding and transcriptional activity has been evaluated. Luciferase reporter assays showed altered repression activity of ARX by all mutations, causing brain malformations and ISSX-ID phenotypes, but not by the P353L mutation implicated in a milder phenotype of XMESID. Similarly, transient overexpression of wild-type ARX repressed endogenous expression of known ARX targets, LMO1 and SHOX2, when measured by real-time quantitative polymerase chain reaction. Overall, the molecular consequence of missense mutations correlated well with the severity of the clinical phenotype. In all mutations tested, except P353L, the DNA binding was abolished. Electrophoretic mobility shift assay results were validated using chromatin immunoprecipitation following overexpression of normal and selected missense mutations. Unlike wild-type ARX and clinically less severe mutations, the mutations leading to severe clinical phenotypes were not able to specifically bind to DNA upstream of known, endogenous ARX-regulated genes, LMO1 and SHOX2. In conclusion, the missense mutations in the ARX homeodomain represent loss-of-function mutations, which lead to a reduced or complete loss of DNA binding and as a consequence, a loss of transcriptional repression.
dc.description.statementofresponsibilityCheryl Shoubridge, May Huey Tan, Grace Seiboth, and Jozef Gécz
dc.identifier.citationHuman Molecular Genetics, 2012; 21(7):1639-1647
dc.identifier.doi10.1093/hmg/ddr601
dc.identifier.issn0964-6906
dc.identifier.issn1460-2083
dc.identifier.orcidShoubridge, C. [0000-0002-0157-3084]
dc.identifier.orcidGecz, J. [0000-0002-7884-6861]
dc.identifier.urihttp://hdl.handle.net/2440/73273
dc.language.isoen
dc.publisherOxford Univ Press
dc.rights© The Author 2011.
dc.source.urihttps://doi.org/10.1093/hmg/ddr601
dc.subjectCell Nucleus
dc.subjectHumans
dc.subjectDNA-Binding Proteins
dc.subjectHomeodomain Proteins
dc.subjectTranscription Factors
dc.subjectRepressor Proteins
dc.subjectDNA
dc.subjectTranscription, Genetic
dc.subjectProtein Structure, Tertiary
dc.subjectActive Transport, Cell Nucleus
dc.subjectMutation, Missense
dc.subjectHEK293 Cells
dc.subjectLIM Domain Proteins
dc.titleARX homeodomain mutations abolish DNA binding and lead to a loss of transcriptional repression
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Paediatrics publications